Homocysteine Is a Marker of Increased Cardio-Cerebrovascular Disease Risk in Psoriatic Patients, but It Does Not Reflect the Effect of Biological Therapy in the Longitudinal Observation

BACKGROUND: Psoriasis is linked to atherosclerosis. Homocysteine (HCYS) has been identified as a marker of increased risk of cardio-cerebrovascular diseases (CCVD) in population. OBJECTIVE: The aim of the study was to determine whether elevated HCYS serves as a marker of increased CCVD in psoriasis...

Descripción completa

Detalles Bibliográficos
Autores principales: Baloghova, Janette, Feketeova, Eva, Kolarcik, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159171/
https://www.ncbi.nlm.nih.gov/pubmed/35685540
http://dx.doi.org/10.1155/2022/3820094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159171/
https://www.ncbi.nlm.nih.gov/pubmed/35685540
http://dx.doi.org/10.1155/2022/3820094

Ejemplares similares